Toshihiko Aranishi
Toshihiko Aranishi publishes mostly in Oncology, Endocrinology, Diabetes and Metabolism and Pulmonary and Respiratory Medicine, on topics such as Diabetes Treatment and Management, Cancer Treatment and Pharmacology and HER2/EGFR in Cancer Research.
- World rank
- #3,716,835 of 7,710,434 ranked researchers
- Rank in Japan
- #94,799 of 383,136
- Works
- 27
- Citations
- 537
- Citations per work
- 19.9
What does Toshihiko Aranishi research?
Toshihiko Aranishi's work is mostly in Medicine (61%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1661.1%
- Medicine1661.1%
- Everything else1138.9%
- 1Oncology18% of their works
- 2Endocrinology, Diabetes and Metabolism17% of their works
- 3Pulmonary and Respiratory Medicine8% of their works
- 4Surgery6% of their works
- 5Rheumatology6% of their works
- 6Dermatology5% of their works
Research topics
Which keywords describe Toshihiko Aranishi's research?
The keywords of their largest research topics: Glycemic Control, Insulin Therapy, Breast Cancer, Chemotherapy, Inflammatory Cytokines, Cardiovascular Outcomes, Chemotherapy-Induced Peripheral Neuropathy and Taxanes.
- Skin Microbiome
- Inflammation
- Filaggrin
- Hypoglycemia
- Cognitive Function
- HER2
- Taxanes
- Cardiovascular Outcomes
- Chemotherapy
- Insulin Therapy
- Glycemic Control
- Breast Cancer
- Inflammatory Cytokines
- Chemotherapy-Induced Peripheral Neuropathy
- Type 2 Diabetes
- Trastuzumab
- Diabetes
- Neuropsychological Impact
- IL-17
- Rheumatoid Arthritis
- TH17 Cells
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Glycemic Control102 topics
- Insulin Therapy102 topics
- Breast Cancer92 topics
- Chemotherapy92 topics
- Inflammatory Cytokines72 topics
- Cardiovascular Outcomes61 topic
- Chemotherapy-Induced Peripheral Neuropathy61 topic
- Taxanes61 topic
- Type 2 Diabetes61 topic
- HER251 topic
- Trastuzumab51 topic
- Cognitive Function41 topic
- Diabetes41 topic
- Hypoglycemia41 topic
- Neuropsychological Impact41 topic
- Filaggrin31 topic
- IL-1731 topic
- Inflammation31 topic
- Rheumatoid Arthritis31 topic
- Skin Microbiome31 topic
- TH17 Cells31 topic
Where does Toshihiko Aranishi work?
Toshihiko Aranishi's main affiliation in the publication record is Eli Lilly (Japan), Japan.
How many publications and citations does Toshihiko Aranishi have?
OpenAlex counts 27 works and 537 citations for Toshihiko Aranishi, an h-index of 9, ranking #3,716,835 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Toshihiko Aranishi. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.